Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Abbie M. Adams"'
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 22, Iss , Pp 263-272 (2020)
Dystrophin plays a crucial role in maintaining sarcolemma stability during muscle contractions, and mutations that prevent the expression of a functional protein cause Duchenne muscular dystrophy (DMD). Antisense oligonucleotide-mediated manipulation
Externí odkaz:
https://doaj.org/article/5194b4eb8cc142648cdf40c35c8296d1
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 155-161 (2017)
Locked nucleic acid is a prominent nucleic acid analog with unprecedented target binding affinity to cDNA and RNA oligonucleotides and shows remarkable stability against nuclease degradation. Incorporation of locked nucleic acid nucleotides into an a
Externí odkaz:
https://doaj.org/article/2e84940904484fa58286d3dd0fbbf405
Autor:
Yue-Bei Luo, Chalermchai Mitrpant, Abbie M Adams, Russell D Johnsen, Sue Fletcher, Frank L Mastaglia, Steve D Wilton
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98306 (2014)
We sought to use splice-switching antisense oligonucleotides to produce a model of accelerated ageing by enhancing expression of progerin, translated from a mis-spliced lamin A gene (LMNA) transcript in human myogenic cells. The progerin transcript (
Externí odkaz:
https://doaj.org/article/9add1f9fedcb42bf851408035e7bef7b
Autor:
Ian J. Constable, Steve D. Wilton, Jennifer A. Thompson, Dan Zhang, May T. Aung-Htut, Abbie M. Adams, Samuel McLenachan, Shang Chih Chen, Terri L. McLaren, Jason Charng, John N. De Roach, Enid Chelva, Tina M. Lamey, Fred K. Chen, Di Huang, Sue Fletcher
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 7, Pp n/a-n/a (2020)
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine
Background Deletion–insertion (delins) variants in the retina‐specific ATP‐binding cassette transporter gene, subfamily A, member 4 (ABCA4) accounts for
This work epitomizes the intrafamilial phenotypic variability in a pseudodominant Star
This work epitomizes the intrafamilial phenotypic variability in a pseudodominant Star
Publikováno v:
JACC: Basic to Translational Science. 3:391-402
Current clinical trials demonstrate Duchenne muscular dystrophy (DMD) patients receiving phosphorodiamidate morpholino oligomer (PMO) therapy exhibit improved ambulation and stable pulmonary function; however, cardiac abnormalities remain. Utilizing
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 155-161 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Locked nucleic acid is a prominent nucleic acid analog with unprecedented target binding affinity to cDNA and RNA oligonucleotides and shows remarkable stability against nuclease degradation. Incorporation of locked nucleic acid nucleotides into an a
Autor:
Emilia Servián-Morilla, A. L. Pelayo-Negro, Macarena Cabrera-Serrano, Fabiola Mavillard, Nigel G. Laing, Abbie M. Adams, Gianina Ravenscroft, Alejandra Carvajal, M. A. Fernández-García, Sue Fletcher, Jose Luis Nieto-Gonzalez, Carmen Paradas, Reimar Junckerstorff, E. Rivas-Infante, J. M. Dyke, Phillipa J. Lamont
Publikováno v:
Acta Neuropathologica Communications
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-16 (2019)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Digital.CSIC. Repositorio Institucional del CSIC
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-16 (2019)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Digital.CSIC. Repositorio Institucional del CSIC
TRIM32 is a E3 ubiquitin -ligase containing RING, B-box, coiled-coil and six C-terminal NHL domains. Mutations involving NHL and coiled-coil domains result in a pure myopathy (LGMD2H/STM) while the only described mutation in the B-box domain is assoc
Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies
Autor:
Chalermchai Mitrpant, Abbie M. Adams, Steve D. Wilton, Ianthe Pitout, Loren L. Flynn, Anja Stirnweiss, Sue Fletcher
Publikováno v:
Biomedicines, Vol 9, Iss 552, p 552 (2021)
Biomedicines
Volume 9
Issue 5
Biomedicines
Volume 9
Issue 5
The literature surrounding the use of antisense oligonucleotides continues to grow, with new disease and mechanistic applications constantly evolving. Furthermore, the discovery and advancement of novel chemistries continues to improve antisense deli
Autor:
Paula T. Cunningham, Mark Anastasas, Tatjana Heinrich, Laura Florez, Danie Champain, Theresa Connor, Paul M. Watt, Nadia Milech, Scott Winslow, Abbie M. Adams, Karen M. Kroeger, Richard W. Francis, Brooke A. C. Longville, Robert E. Dewhurst, Shane R. Stone, Yew Foon Tan, M. Scobie, Clinton M. Hall, Helena M. Viola, Maria Kerfoot, Livia C. Hool, Heique M. Bogdawa, Arne Skerra, Katrin Hoffmann, Ferrer Ong, Volker Morath, Suzy M. Juraja, Sue Fletcher, Gregory A. Weiss, Richard Hopkins
Publikováno v:
Scientific reports, vol 8, iss 1
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-16 (2018)
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-16 (2018)
Cell penetrating peptides (CPPs) offer great potential to deliver therapeutic molecules to previously inaccessible intracellular targets. However, many CPPs are inefficient and often leave their attached cargo stranded in the cell’s endosome. We re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2982281cc58305b13bc410a28e61452e
https://escholarship.org/uc/item/9539k69b
https://escholarship.org/uc/item/9539k69b
Autor:
Abbie M. Adams, C. Adkin, Penelope L. Meloni, Steve D. Wilton, Francesco Muntoni, Sue Fletcher, Brenda Wong
Publikováno v:
Neuromuscular Disorders
Manipulation of dystrophin pre-mRNA processing offers the potential to overcome mutations in the dystrophin gene that would otherwise lead to Duchenne muscular dystrophy. Dystrophin mutations will require the removal of one or more exons to restore t